statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Qualigen Therapeutics, Inc. (NASDAQ:QLGN - Get Free Report) rose 1.3% on Tuesday . The stock traded as high as $0.45 and last traded at $0.40. Approximately 88,072 shares traded hands...

Qualigen Therapeutics (NASDAQ:QLGN) Trading 1.3% Higher

The latest update is out from Qualigen Therapeutics Inc (QLGN). A Termination Agreement was finalized on March 25, 2024, ending a prior arrangement...

Qualigen Therapeutics Ends Deal with Pan-RAS Holdings

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.

Qualigen Therapeutics Inc

Volume	9,216.00
52-Wk High	$1.26
52-Wk Low	$0.2831

QLGN Qualigen Therapeutics Inc

About

Feed

News

Sentiment

Fundamentals